| Dr James Ronald Hirsch, MD | |
|
6701 Airport Blvd Ste D146, Mobile, AL 36608-6701 | |
| (251) 287-2176 | |
| (251) 287-2279 |
| Full Name | Dr James Ronald Hirsch |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 32 Years |
| Location | 6701 Airport Blvd Ste D146, Mobile, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609867803 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 33723 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Hospital | Mobile, AL | Hospital |
| Springhill Medical Center | Mobile, AL | Hospital |
| Singing River Health System | Pascagoula, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shawn Clark, Md, Pc | 0143459776 | 4 |
News Archive
Researchers at the Gladstone Institutes and University of California, San Francisco have shown that a loss of cells in the retina is one of the earliest signs of frontotemporal dementia (FTD) in people with a genetic risk for the disorder-even before any changes appear in their behavior.
Molecular Detection Inc., a company developing Detect-Ready assays designed to increase the speed and accuracy of infectious disease diagnosis, today announced the first close of a new financing. The financing was led by MentorTech Ventures II, LP and included Robin Hood Ventures, Elm Spring Holdings and the Mid-Atlantic Angel Group Fund I and II, LP, all existing investors. The company raised $1.4 million as part of a follow-on to its $3.3 million Series C round announced in late 2009.
Athersys, Inc. and its collaborators, including the Center for Stem Cell and Regenerative Medicine and Case Western Reserve University, announced today that they have been awarded $1 million through the Ohio Third Frontier Biomedical Program to support research into the treatment of spinal cord injury with MultiStem, Athersys' proprietary stem cell product candidate.
When Sociologist Rene Almeling decided to look into the operations of U.S. sperm banks and egg agencies, the UCLA Ph.D. candidate in sociology thought she knew what she would find.
The interindividual variability of response to subcutaneously applied protein-based drugs remains poorly understood. However, defining genetic markers that can be associated with biological effects of such drugs may improve the understanding of individual variability of response and even drug resistance.
› Verified 4 days ago
| Entity Name | Shawn Clark, Md, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972931533 PECOS PAC ID: 0143459776 Enrollment ID: O20140131000697 |
News Archive
Researchers at the Gladstone Institutes and University of California, San Francisco have shown that a loss of cells in the retina is one of the earliest signs of frontotemporal dementia (FTD) in people with a genetic risk for the disorder-even before any changes appear in their behavior.
Molecular Detection Inc., a company developing Detect-Ready assays designed to increase the speed and accuracy of infectious disease diagnosis, today announced the first close of a new financing. The financing was led by MentorTech Ventures II, LP and included Robin Hood Ventures, Elm Spring Holdings and the Mid-Atlantic Angel Group Fund I and II, LP, all existing investors. The company raised $1.4 million as part of a follow-on to its $3.3 million Series C round announced in late 2009.
Athersys, Inc. and its collaborators, including the Center for Stem Cell and Regenerative Medicine and Case Western Reserve University, announced today that they have been awarded $1 million through the Ohio Third Frontier Biomedical Program to support research into the treatment of spinal cord injury with MultiStem, Athersys' proprietary stem cell product candidate.
When Sociologist Rene Almeling decided to look into the operations of U.S. sperm banks and egg agencies, the UCLA Ph.D. candidate in sociology thought she knew what she would find.
The interindividual variability of response to subcutaneously applied protein-based drugs remains poorly understood. However, defining genetic markers that can be associated with biological effects of such drugs may improve the understanding of individual variability of response and even drug resistance.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Ronald Hirsch, MD 6701 Airport Blvd, Ste D146, Mobile, AL 36608-6701 Ph: (251) 287-2176 | Dr James Ronald Hirsch, MD 6701 Airport Blvd Ste D146, Mobile, AL 36608-6701 Ph: (251) 287-2176 |
News Archive
Researchers at the Gladstone Institutes and University of California, San Francisco have shown that a loss of cells in the retina is one of the earliest signs of frontotemporal dementia (FTD) in people with a genetic risk for the disorder-even before any changes appear in their behavior.
Molecular Detection Inc., a company developing Detect-Ready assays designed to increase the speed and accuracy of infectious disease diagnosis, today announced the first close of a new financing. The financing was led by MentorTech Ventures II, LP and included Robin Hood Ventures, Elm Spring Holdings and the Mid-Atlantic Angel Group Fund I and II, LP, all existing investors. The company raised $1.4 million as part of a follow-on to its $3.3 million Series C round announced in late 2009.
Athersys, Inc. and its collaborators, including the Center for Stem Cell and Regenerative Medicine and Case Western Reserve University, announced today that they have been awarded $1 million through the Ohio Third Frontier Biomedical Program to support research into the treatment of spinal cord injury with MultiStem, Athersys' proprietary stem cell product candidate.
When Sociologist Rene Almeling decided to look into the operations of U.S. sperm banks and egg agencies, the UCLA Ph.D. candidate in sociology thought she knew what she would find.
The interindividual variability of response to subcutaneously applied protein-based drugs remains poorly understood. However, defining genetic markers that can be associated with biological effects of such drugs may improve the understanding of individual variability of response and even drug resistance.
› Verified 4 days ago
Jeremy W Amps, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6701 Airport Blvd, Suite D146, Mobile, AL 36608 Phone: 251-633-5155 Fax: 251-633-5125 | |
Dr. Donald R Tyler, M. D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3280 Dauphin St, Building A, Mobile, AL 36606 Phone: 251-450-3700 Fax: 251-662-3819 | |
Amber Shea Gordon, M.D. Neurological Surgery Medicare: May Accept Medicare Assignments Practice Location: 3 Mobile Infirmary Cir Ste 410, Mobile, AL 36607 Phone: 251-435-6850 Fax: 251-435-6859 | |
Dr. Shawn B Clark, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6701 Airport Blvd Ste D146, Mobile, AL 36608 Phone: 251-287-2176 Fax: 251-287-2279 | |
Andrew Kessler Romeo, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1601 Center St, Mobile, AL 36604 Phone: 251-660-5108 Fax: 251-660-5792 | |
Dr. Edward R Flotte, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3280 Dauphin St, Building A, Mobile, AL 36606 Phone: 251-450-3700 Fax: 251-662-3819 |